We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Metal-free Contrast Agent May Be Safer for Patients

By MedImaging International staff writers
Posted on 25 Jul 2017
Print article
Image: Researchers have developed a safer hydroxide organic MRI contrast agent, as an alternative to metal based ones, for young children and other high-risk patients (Photo courtesy of MIT / University of Nebraska).
Image: Researchers have developed a safer hydroxide organic MRI contrast agent, as an alternative to metal based ones, for young children and other high-risk patients (Photo courtesy of MIT / University of Nebraska).
Researchers have developed a new metal-free MRI contrast agent that could be used for high-risk patient groups and make longer-term tumor imaging more feasible.

Magnetic Resonance Imaging (MRI) tumor imaging scans are often used together with intravenous contrast agents, most commonly gadolinium-based ones. These agents contain metal compounds that can be harmful for patients with kidney problems, and for young children.

Now researchers at the Massachusetts Institute of Technology (MIT; Boston, MA, USA), and the University of Nebraska (Lincoln, NB, USA) have developed an organic nitroxide-based metal-free contrast agent that is safer for these high-risk groups. The new agent also accumulates for longer at a tumor site providing more data for MRI scans.

The researchers loaded the nitroxide agent into a spherical Brush-Arm Star Polymer (BASP) structure with a hydrophilic core and a hydrophobic shell. They also found that they could substantially increase the MRI relaxivity of the agent, to around the level of metal-based agents. The BASP shell protects the radicals in the bloodstream allowing them to survive for up to 20 hours.

The new contrast agent could also be modified to carry drugs, in addition to the MRI contrast agent, and allow for long-term imaging and follow-up treatments to monitor whether the drug is able to shrink the tumor. Another possibility under investigation is combining the contrast agent particles with antibodies that can target specific cells.

Senior author of the study, associate professor of Chemistry at MIT, Jeremiah Johnson, said, “This is an entirely organic, metal-free MRI contrast agent that would allow cancer researchers to start to think about how to image tumors in a dynamic way over long periods of time.

Related Links:
Massachusetts Institute of Technology
University of Nebraska

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Area Product Meter
VacuDAP
New
Portable X-Ray Unit
AJEX240H
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.